Roble Belko & Company’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-20
| Closed | -$1K | – | 430 |
|
|
2024
Q4 | $1K | Hold |
20
| – | – | ﹤0.01% | 347 |
|
|
2024
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 378 |
|
|
2024
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 362 |
|
|
2024
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 347 |
|
|
2023
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 341 |
|
|
2023
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 314 |
|
|
2023
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 274 |
|
|
2023
Q1 | $1K | Hold |
20
| – | – | ﹤0.01% | 280 |
|
|
2022
Q4 | $1K | Hold |
20
| – | – | ﹤0.01% | 303 |
|
|
2022
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 289 |
|
|
2022
Q2 | $1K | Sell |
20
-7
| -26% | -$350 | ﹤0.01% | 302 |
|
|
2022
Q1 | $2K | Sell |
27
-47
| -64% | -$3.48K | ﹤0.01% | 343 |
|
|
2021
Q4 | $6K | Sell |
74
-6
| -8% | -$486 | ﹤0.01% | 279 |
|
|
2021
Q3 | $9K | Sell |
80
-20
| -20% | -$2.25K | ﹤0.01% | 247 |
|
|
2021
Q2 | $22K | Buy |
+100
| New | +$22K | 0.01% | 207 |
|
|
2020
Q4 | – | Sell |
-100
| Closed | -$11K | – | 328 |
|
|
2020
Q3 | $11K | Hold |
100
| – | – | ﹤0.01% | 234 |
|
|
2020
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 274 |
|
|
2020
Q1 | $7K | Hold |
100
| – | – | ﹤0.01% | 271 |
|
|
2019
Q4 | $8K | Hold |
100
| – | – | ﹤0.01% | 277 |
|
|
2019
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 276 |
|
|
2019
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 281 |
|
|
2019
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 264 |
|
|
2018
Q4 | $3K | Hold |
100
| – | – | ﹤0.01% | 274 |
|
|
2018
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 269 |
|
|
2018
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 292 |
|
|
2018
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 309 |
|
|
2017
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 295 |
|
|
2017
Q3 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 264 |
|